Biogen
-
News
Biogen Ceases Development of Aduhelm, Alzheimer’s Drug
Biogen, a leading pharmaceutical company, has announced its decision to discontinue the development of its Alzheimer’s drug, Aduhelm. Once hailed…
Read More »
Biogen, a leading pharmaceutical company, has announced its decision to discontinue the development of its Alzheimer’s drug, Aduhelm. Once hailed…
Read More »